{"id":5116,"date":"2024-04-17T00:08:03","date_gmt":"2024-04-17T04:08:03","guid":{"rendered":"https:\/\/colpittsclinical.com\/?p=5116"},"modified":"2024-04-21T23:52:52","modified_gmt":"2024-04-22T03:52:52","slug":"supporting-patients-with-fabry-disease-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/colpittsclinical.com\/cs\/supporting-patients-with-fabry-disease-in-clinical-trials\/","title":{"rendered":"Podpora pacient\u016f s Fabryho chorobou v klinick\u00fdch studi\u00edch"},"content":{"rendered":"

P\u0159eklenut\u00ed mezery: podpora pacient\u016f s Fabryho chorobou prost\u0159ednictv\u00edm klinick\u00fdch studi\u00ed<\/b><\/h2>\n

Duben je m\u011bs\u00edc v\u011bnovan\u00fd zvy\u0161ov\u00e1n\u00ed pov\u011bdom\u00ed o Fabryho chorob\u011b, vz\u00e1cn\u00e9 genetick\u00e9 poru\u0161e, kter\u00e1 postihuje tis\u00edce lid\u00ed na cel\u00e9m sv\u011bt\u011b. Ve spole\u010dnosti Colpitts Clinical si uv\u011bdomujeme, \u017ee je d\u016fle\u017eit\u00e9 podporovat pacienty \u017eij\u00edc\u00ed se vz\u00e1cn\u00fdmi onemocn\u011bn\u00edmi, jako je Fabryho choroba, a zajistit jim p\u0159\u00edstup ke \u0161pi\u010dkov\u00e9 l\u00e9\u010db\u011b prost\u0159ednictv\u00edm klinick\u00fdch studi\u00ed. V tomto p\u0159\u00edsp\u011bvku se budeme zab\u00fdvat v\u00fdznamem M\u011bs\u00edce informovanosti o Fabryho chorob\u011b a t\u00edm, jak spole\u010dnost Colpitts Clinical hraje d\u016fle\u017eitou roli p\u0159i p\u0159eklenov\u00e1n\u00ed propasti mezi pacienty a l\u00e9\u010dbou, kter\u00e1 je pro n\u011b dostupn\u00e1.<\/p>\n

Porozum\u011bn\u00ed Fabryho chorob\u011b:<\/i><\/strong><\/p>\n

Fabryho choroba je vz\u00e1cn\u00e9 genetick\u00e9 onemocn\u011bn\u00ed zp\u016fsoben\u00e9 nedostatkem enzymu zvan\u00e9ho alfa-galaktosid\u00e1za A (\u03b1-Gal A). Deficit tohoto enzymu vede k hromad\u011bn\u00ed ur\u010dit\u00fdch tuk\u016f, p\u0159edev\u0161\u00edm globotriaosylceramidu (Gb3), v r\u016fzn\u00fdch bu\u0148k\u00e1ch v cel\u00e9m t\u011ble. Toto hromad\u011bn\u00ed m\u016f\u017ee \u010dasem vy\u00fastit v celou \u0159adu p\u0159\u00edznak\u016f, v\u010detn\u011b bolesti, poruchy funkce ledvin, srde\u010dn\u00edch komplikac\u00ed a neurologick\u00fdch probl\u00e9m\u016f. P\u0159esto\u017ee se jedn\u00e1 o vz\u00e1cn\u00e9 onemocn\u011bn\u00ed, m\u016f\u017ee m\u00edt Fabryho choroba v\u00fdznamn\u00fd dopad na \u017eivot pacient\u016f a ovlivnit kvalitu jejich \u017eivota a celkov\u00fd zdravotn\u00ed stav.<\/p>\n

Role Colpitts Clinical:<\/i><\/strong><\/p>\n

Ve spole\u010dnosti Colpitts Clinical rozum\u00edme v\u00fdzv\u00e1m, kter\u00fdm \u010del\u00ed pacienti se vz\u00e1cn\u00fdmi onemocn\u011bn\u00edmi, v\u010detn\u011b p\u0159\u00edstupu ke specializovan\u00e9 p\u00e9\u010di a \u00fa\u010dasti v klinick\u00fdch studi\u00edch. Proto se sna\u017e\u00edme p\u0159eklenout propast mezi pacienty a l\u00e9\u010dbou, kter\u00e1 je pro n\u011b dostupn\u00e1. N\u00e1\u0161 t\u00fdm \u00fazce spolupracuje se zadavateli studi\u00ed, v\u00fdzkumn\u00fdmi institucemi a CRO s c\u00edlem usnadnit klinick\u00e9 studie Fabryho choroby a dal\u0161\u00edch vz\u00e1cn\u00fdch onemocn\u011bn\u00ed.<\/p>\n

C\u00edlem na\u0161ich komplexn\u00edch podp\u016frn\u00fdch slu\u017eeb je, aby klinick\u00e9 hodnocen\u00ed prob\u011bhlo pro pacienty co nejplynuleji. Sna\u017e\u00edme se zm\u00edrnit z\u00e1t\u011b\u017e, kter\u00e1 je \u010dasto spojena s \u00fa\u010dast\u00ed ve v\u00fdzkumn\u00fdch studi\u00edch, od poskytov\u00e1n\u00ed vzd\u011bl\u00e1v\u00e1n\u00ed a poradenstv\u00ed a\u017e po koordinaci cestov\u00e1n\u00ed a logistiky. Krom\u011b toho up\u0159ednost\u0148ujeme bezpe\u010dnost a pohodu pacient\u016f v pr\u016fb\u011bhu cel\u00e9ho procesu studie a zaji\u0161\u0165ujeme, aby se \u00fa\u010dastn\u00edk\u016fm dostalo p\u00e9\u010de na nejvy\u0161\u0161\u00ed \u00farovni.<\/p>\n

Jak m\u016f\u017eete pomoci?<\/i><\/strong><\/p>\n

Zapojte se:<\/b>\u00a0B\u011bhem m\u011bs\u00edce informovanosti o Fabryho chorob\u011b i mimo n\u011bj existuje n\u011bkolik zp\u016fsob\u016f, jak se zapojit a podpo\u0159it osoby \u017eij\u00edc\u00ed s Fabryho chorobou:<\/p>\n

Zvy\u0161ov\u00e1n\u00ed pov\u011bdom\u00ed:<\/b>\u00a0Sd\u00edlejte informace o Fabryho chorob\u011b na soci\u00e1ln\u00edch s\u00edt\u00edch, po\u0159\u00e1dejte osv\u011btov\u00e9 akce nebo se zapojte do m\u00edstn\u00edch podp\u016frn\u00fdch aktivit.<\/p>\n

Podpora v\u00fdzkumu:<\/b>\u00a0Zva\u017ete mo\u017enost p\u0159isp\u011bt organizac\u00edm, kter\u00e9 se v\u011bnuj\u00ed financov\u00e1n\u00ed v\u00fdzkumu Fabryho choroby, nebo se p\u0159ihl\u00e1sit jako dobrovoln\u00edk do klinick\u00fdch studi\u00ed, pokud na n\u011b m\u00e1te n\u00e1rok.<\/p>\n

Zasazujte se o p\u0159\u00edstup:<\/b>\u00a0Prosazovat politiky, kter\u00e9 zajist\u00ed p\u0159\u00edstup k cenov\u011b dostupn\u00e9 l\u00e9\u010db\u011b a podp\u016frn\u00fdm slu\u017eb\u00e1m pro osoby se vz\u00e1cn\u00fdmi onemocn\u011bn\u00edmi.<\/p>\n

Spole\u010dn\u011b m\u016f\u017eeme zm\u011bnit \u017eivoty pacient\u016f s Fabryho chorobou a dal\u0161\u00edmi vz\u00e1cn\u00fdmi onemocn\u011bn\u00edmi.<\/p>\n

M\u011bs\u00edc informovanosti o Fabryho chorob\u011b p\u0159ipom\u00edn\u00e1, jak je d\u016fle\u017eit\u00e9 podporovat osoby \u017eij\u00edc\u00ed se vz\u00e1cn\u00fdmi chorobami a podporovat v\u00fdzkumn\u00e9 \u00fasil\u00ed o nalezen\u00ed \u00fa\u010dinn\u00e9 l\u00e9\u010dby. Ve spole\u010dnosti Colpitts Clinical se sna\u017e\u00edme posilovat postaven\u00ed pacient\u016f s Fabryho chorobou prost\u0159ednictv\u00edm na\u0161ich komplexn\u00edch podp\u016frn\u00fdch slu\u017eeb a usnad\u0148ovat p\u0159\u00edstup k inovativn\u00edm terapi\u00edm prost\u0159ednictv\u00edm klinick\u00fdch studi\u00ed. Spole\u010dnou prac\u00ed m\u016f\u017eeme pokro\u010dit ve zlep\u0161ov\u00e1n\u00ed \u017eivota lid\u00ed posti\u017een\u00fdch Fabryho chorobou a dal\u0161\u00edmi vz\u00e1cn\u00fdmi onemocn\u011bn\u00edmi. P\u0159ipojte se k n\u00e1m p\u0159i zvy\u0161ov\u00e1n\u00ed pov\u011bdom\u00ed, podpo\u0159e v\u00fdzkumu a prosazov\u00e1n\u00ed dostupnosti p\u00e9\u010de. Spole\u010dn\u011b m\u016f\u017eeme p\u0159eklenout propast a p\u0159in\u00e9st nad\u011bji pacient\u016fm a jejich rodin\u00e1m.<\/p>\n

 <\/p>\n

P\u0159e\u010dt\u011bte si v\u00edce o klinick\u00fdch zkou\u0161k\u00e1ch<\/strong><\/em><\/p>\n

Jak cestovn\u00ed slu\u017eby vytv\u00e1\u0159ej\u00ed lep\u0161\u00ed zku\u0161enosti s cestov\u00e1n\u00edm v r\u00e1mci klinick\u00fdch studi\u00ed<\/a><\/p>\n

Z\u00e1sadn\u00ed role klinick\u00fdch studi\u00ed a koordinace podp\u016frn\u00fdch cest<\/a><\/p>\n

U\u010dinit nemo\u017en\u00e9 mo\u017en\u00fdm<\/a><\/p>\n

Nav\u0161tivte n\u00e1s na\u00a0Facebook<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Bridging the Gap: Supporting Patients with Fabry Disease Through Clinical Trials April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide. At Colpitts Clinical, we recognize the importance of supporting patients living with rare diseases like Fabry and ensuring they have access to cutting-edge […]<\/p>\n","protected":false},"author":1,"featured_media":5132,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[6,30],"tags":[],"class_list":["post-5116","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-trials","category-rare-diseases"],"yoast_head":"\nSupporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical<\/title>\n<meta name=\"description\" content=\"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/colpittsclinical.com\/cs\/supporting-patients-with-fabry-disease-in-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"cs_CZ\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical\" \/>\n<meta property=\"og:description\" content=\"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/colpittsclinical.com\/cs\/supporting-patients-with-fabry-disease-in-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Colpitts Clinical\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ColpittsClinicalTrialTravel\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-17T04:08:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-22T03:52:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"828\" \/>\n\t<meta property=\"og:image:height\" content=\"420\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"clinical\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napsal(a)\" \/>\n\t<meta name=\"twitter:data1\" content=\"clinical\" \/>\n\t<meta name=\"twitter:label2\" content=\"Odhadovan\u00e1 doba \u010dten\u00ed\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\"},\"author\":{\"name\":\"clinical\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/person\\\/7f5c1f500aa2df676ac51a2c6236e2fd\"},\"headline\":\"Supporting Patients with Fabry Disease in Clinical Trials\",\"datePublished\":\"2024-04-17T04:08:03+00:00\",\"dateModified\":\"2024-04-22T03:52:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\"},\"wordCount\":542,\"publisher\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"articleSection\":[\"Clinical Trials\",\"Rare Diseases\"],\"inLanguage\":\"cs\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\",\"name\":\"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"datePublished\":\"2024-04-17T04:08:03+00:00\",\"dateModified\":\"2024-04-22T03:52:52+00:00\",\"description\":\"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"cs\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"width\":828,\"height\":420,\"caption\":\"Supporting patients with Fabry disease\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/colpittsclinical.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Supporting Patients with Fabry Disease in Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#website\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/\",\"name\":\"Colpitts Clinical\",\"description\":\"patient-liaison\",\"publisher\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/colpittsclinical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"cs\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#organization\",\"name\":\"Colpitts Clinical\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/cc-logo-212-1.png\",\"contentUrl\":\"https:\\\/\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/cc-logo-212-1.png\",\"width\":212,\"height\":48,\"caption\":\"Colpitts Clinical\"},\"image\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ColpittsClinicalTrialTravel\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/colpittsclinical\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/person\\\/7f5c1f500aa2df676ac51a2c6236e2fd\",\"name\":\"clinical\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g\",\"caption\":\"clinical\"},\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/cs\\\/author\\\/cclinical\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical","description":"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/colpittsclinical.com\/cs\/supporting-patients-with-fabry-disease-in-clinical-trials\/","og_locale":"cs_CZ","og_type":"article","og_title":"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical","og_description":"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.","og_url":"https:\/\/colpittsclinical.com\/cs\/supporting-patients-with-fabry-disease-in-clinical-trials\/","og_site_name":"Colpitts Clinical","article_publisher":"https:\/\/www.facebook.com\/ColpittsClinicalTrialTravel\/","article_published_time":"2024-04-17T04:08:03+00:00","article_modified_time":"2024-04-22T03:52:52+00:00","og_image":[{"width":828,"height":420,"url":"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg","type":"image\/jpeg"}],"author":"clinical","twitter_card":"summary_large_image","twitter_misc":{"Napsal(a)":"clinical","Odhadovan\u00e1 doba \u010dten\u00ed":"3 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/"},"author":{"name":"clinical","@id":"https:\/\/colpittsclinical.com\/#\/schema\/person\/7f5c1f500aa2df676ac51a2c6236e2fd"},"headline":"Supporting Patients with Fabry Disease in Clinical Trials","datePublished":"2024-04-17T04:08:03+00:00","dateModified":"2024-04-22T03:52:52+00:00","mainEntityOfPage":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/"},"wordCount":542,"publisher":{"@id":"https:\/\/colpittsclinical.com\/#organization"},"image":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","articleSection":["Clinical Trials","Rare Diseases"],"inLanguage":"cs"},{"@type":"WebPage","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/","url":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/","name":"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical","isPartOf":{"@id":"https:\/\/colpittsclinical.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","datePublished":"2024-04-17T04:08:03+00:00","dateModified":"2024-04-22T03:52:52+00:00","description":"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.","breadcrumb":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#breadcrumb"},"inLanguage":"cs","potentialAction":[{"@type":"ReadAction","target":["https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage","url":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","contentUrl":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","width":828,"height":420,"caption":"Supporting patients with Fabry disease"},{"@type":"BreadcrumbList","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/colpittsclinical.com\/"},{"@type":"ListItem","position":2,"name":"Supporting Patients with Fabry Disease in Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/colpittsclinical.com\/#website","url":"https:\/\/colpittsclinical.com\/","name":"Colpitts Clinical","description":"pacient-liaison","publisher":{"@id":"https:\/\/colpittsclinical.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/colpittsclinical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"cs"},{"@type":"Organization","@id":"https:\/\/colpittsclinical.com\/#organization","name":"Colpitts Clinical","url":"https:\/\/colpittsclinical.com\/","logo":{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/colpittsclinical.com\/#\/schema\/logo\/image\/","url":"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2017\/10\/cc-logo-212-1.png","contentUrl":"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2017\/10\/cc-logo-212-1.png","width":212,"height":48,"caption":"Colpitts Clinical"},"image":{"@id":"https:\/\/colpittsclinical.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ColpittsClinicalTrialTravel\/","https:\/\/www.linkedin.com\/company\/colpittsclinical\/"]},{"@type":"Person","@id":"https:\/\/colpittsclinical.com\/#\/schema\/person\/7f5c1f500aa2df676ac51a2c6236e2fd","name":"klinick\u00fd","image":{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/secure.gravatar.com\/avatar\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g","caption":"clinical"},"url":"https:\/\/colpittsclinical.com\/cs\/author\/cclinical\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/posts\/5116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/comments?post=5116"}],"version-history":[{"count":4,"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/posts\/5116\/revisions"}],"predecessor-version":[{"id":5122,"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/posts\/5116\/revisions\/5122"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/media\/5132"}],"wp:attachment":[{"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/media?parent=5116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/categories?post=5116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/colpittsclinical.com\/cs\/wp-json\/wp\/v2\/tags?post=5116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}